Similar articles for PMID: 22541676

Year	Number of Results
1976	1
1983	1
1989	2
1990	4
1992	2
1994	1
1995	2
1997	1
1999	3
2000	1
2003	1
2004	2
2005	1
2006	4
2007	2
2008	4
2009	1
2010	5
2011	6
2012	8
2013	2
2014	2
2015	5
2016	3
2019	1
2020	3
2021	1
2022	2
2023	2
2024	0

1

Intractable membranous lupus nephritis showing selective improvement of subepithelial deposits with tacrolimus therapy: a case report.

Nonaka K, Ubara Y, Suwabe T, Takaichi K, Oohashi K. Nonaka K, et al. Clin Nephrol. 2013 Aug;80(2):140-5. doi: 10.5414/CN107093. Clin Nephrol. 2013. PMID: 22541676

2

Prolonged membranous lupus nephritis with change of anti-ssDNA antibody titer and repeated renal relapse.

Yumura W, Suganuma S, Nitta K, Sano Y, Uchida K, Nihei H. Yumura W, et al. Clin Exp Nephrol. 2004 Dec;8(4):363-8. doi: 10.1007/s10157-004-0306-y. Clin Exp Nephrol. 2004. PMID: 15619038

3

Good response of membranous lupus nephritis to tacrolimus.

Maruyama M, Yamasaki Y, Sada K, Sarai A, Ujike K, Maeshima Y, Nakamura Y, Sugiyama H, Makino H. Maruyama M, et al. Clin Nephrol. 2006 Apr;65(4):276-9. doi: 10.5414/cnp65276. Clin Nephrol. 2006. PMID: 16629227

4

Study of lupus nephritis: its classification and the significance of subendothelial deposits.

Tateno S, Kobayashi Y, Shigematsu H, Hiki Y. Tateno S, et al. Q J Med. 1983 Summer;52(207):311-31. Q J Med. 1983. PMID: 6359226

5

A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade.

Tse KC, Lam MF, Tang SC, Tang CS, Chan TM. Tse KC, et al. Lupus. 2007;16(1):46-51. doi: 10.1177/0961203306073167. Lupus. 2007. PMID: 17283585

6

Tacrolimus Induction Therapy for Nephrotic Syndrome Caused by Minimal Mesangial Lupus Nephritis with Lupus Podocytopathy: A Case-Based Review.

Kurihara I, Terai C, Yabe H, Sugawara H. Kurihara I, et al. Am J Case Rep. 2022 Nov 7;23:e937201. doi: 10.12659/AJCR.937201. Am J Case Rep. 2022. PMID: 36336892 Free PMC article.

7

Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.

Szeto CC, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Gang W, Li PK. Szeto CC, et al. Rheumatology (Oxford). 2008 Nov;47(11):1678-81. doi: 10.1093/rheumatology/ken335. Epub 2008 Aug 27. Rheumatology (Oxford). 2008. PMID: 18753192

8

[A case report of lupus nephritis associated with minimal change nephrotic syndrome--comparison of various histological types of 67 cases with lupus nephritis].

Okai T, Soejima A, Suzuki M, Yomogida S, Nakabayashi K, Kitamoto K, Nagasawa T. Okai T, et al. Nihon Jinzo Gakkai Shi. 1992 Jul;34(7):835-40. Nihon Jinzo Gakkai Shi. 1992. PMID: 1479724 Japanese.

9

Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study.

Wang S, Li X, Qu L, Wang R, Chen Y, Li Q, He X, Zhang X, Wang H, Wu J, Xu Y, Chen J. Wang S, et al. Lupus. 2012 Aug;21(9):1025-35. doi: 10.1177/0961203312448105. Epub 2012 May 8. Lupus. 2012. PMID: 22570338

10

Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.

Ito S, Kuriyama H, Iino N, Iguchi S, Shimada H, Ueno M, Narita I, Nakano M, Nishi S, Karasawa R, Gejyo F. Ito S, et al. Clin Exp Nephrol. 2003 Dec;7(4):290-5. doi: 10.1007/s10157-003-0244-0. Clin Exp Nephrol. 2003. PMID: 14712359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

65 results

Results by year